244 related articles for article (PubMed ID: 29494436)
21. Primary central nervous system lymphoma with systemic metastasis: case report and review.
Brown MT; McClendon RE; Gockerman JP
J Neurooncol; 1995; 23(3):207-21. PubMed ID: 7673983
[TBL] [Abstract][Full Text] [Related]
22. [Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings].
Liu HY; Zhang XL; Chen YP; Qiu SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):333-6. PubMed ID: 19246316
[TBL] [Abstract][Full Text] [Related]
23. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
[TBL] [Abstract][Full Text] [Related]
24. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
25. Different imaging patterns of PCNSL and IVL: a case report.
Jeon SH; Kang MK; Lee SJ; Shin BS; Kang HG
BMC Neurol; 2019 Dec; 19(1):311. PubMed ID: 31795989
[TBL] [Abstract][Full Text] [Related]
26. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Schlegel U; Jürgens A; Pels H
Neurology; 2006 Apr; 66(8):1287; author reply 1287. PubMed ID: 16636266
[No Abstract] [Full Text] [Related]
27. Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?
Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Maeshima A; Kayama T; Shibui S
Clin Neurol Neurosurg; 2012 Nov; 114(9):1217-21. PubMed ID: 22445618
[TBL] [Abstract][Full Text] [Related]
28. Spinal primary central nervous system lymphoma: Case report and literature review.
Feng L; Chen D; Zhou H; Shen C; Wang H; Sun X; Liang X; Chen L
J Clin Neurosci; 2018 Apr; 50():16-19. PubMed ID: 29429785
[TBL] [Abstract][Full Text] [Related]
29. Neuroimaging of primary central nervous system lymphoma in immunocompetent patients: comparison of recent and previous findings.
Adachi K; Yamaguchi F; Node Y; Kobayashi S; Takagi R; Teramoto A
J Nippon Med Sch; 2013; 80(3):174-83. PubMed ID: 23832401
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic Diagnosis Using 5-Aminolevulinic Acid in 41 Biopsies for Primary Central Nervous System Lymphoma.
Yamamoto T; Ishikawa E; Miki S; Sakamoto N; Zaboronok A; Matsuda M; Akutsu H; Nakai K; Tsuruta W; Matsumura A
Photochem Photobiol; 2015 Nov; 91(6):1452-7. PubMed ID: 26277101
[TBL] [Abstract][Full Text] [Related]
31. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
[TBL] [Abstract][Full Text] [Related]
32. Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.
Deutsch MB; Mendez MF
Cogn Behav Neurol; 2015 Mar; 28(1):1-10. PubMed ID: 25812125
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of primary central nervous system lymphomas from high grade astrocytomas by qualitative analysis of the signal intensity curves derived from dynamic susceptibility-contrast magnetic resonance imaging.
Jensen-Kondering U; Henker C; Dörner L; Hugo HH; Jansen O
Neurol Res; 2012 Dec; 34(10):984-8. PubMed ID: 23146301
[TBL] [Abstract][Full Text] [Related]
34. A case of primary central nervous system lymphoma presenting diffuse infiltrative leukoencephalopathy.
Yamamoto T; Kojima K; Koibuchi K; Ito S; Higuchi Y; Iwadate Y; Oide T; Kuwabara S
Intern Med; 2012; 51(9):1103-6. PubMed ID: 22576396
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.
Palmedo H; Urbach H; Bender H; Schlegel U; Schmidt-Wolf IG; Matthies A; Linnebank M; Joe A; Bucerius J; Biersack HJ; Pels H
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):164-8. PubMed ID: 16220304
[TBL] [Abstract][Full Text] [Related]
36. Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy.
Chen C; Zhuo H; Wei X; Ma X
Contrast Media Mol Imaging; 2019; 2019():5481491. PubMed ID: 31777472
[TBL] [Abstract][Full Text] [Related]
37. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
Zhou XQ; Liu XQ; Kong JC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
[TBL] [Abstract][Full Text] [Related]
38. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
39. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.
Haldorsen IS; Kråkenes J; Krossnes BK; Mella O; Espeland A
AJNR Am J Neuroradiol; 2009 Apr; 30(4):744-51. PubMed ID: 19164442
[TBL] [Abstract][Full Text] [Related]
40. A case with coincidental diagnosis of primary central nervous system lymphoma and lymph node sarcoidosis.
Greiner EJ; Mügge LO; Romeike BF; Topalidis T; Theis B; Ragoschke-Schumm A; Witte OW; Günther A
J Neurooncol; 2010 Aug; 99(1):129-34. PubMed ID: 20054702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
